(VIANEWS) - Washington Federal (WAFD), Saratoga Investment Corp New (SAR), Zynex (ZYXI) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Washington Federal (WAFD)
32.6% sales growth and 10.74% return on equity
Washington Federal, Inc. operates as the bank holding company for Washington Federal Bank, National Association that provides lending, depository, insurance, and other banking services in the United States. The company accepts deposit products, including business and personal checking accounts, and term certificates of deposit, as well as money market accounts and passbook savings accounts. It also provides single-family residential, construction, land acquisition and development, consumer lot, multi-family residential, commercial and industrial, commercial real estate, home equity, and consumer loans. In addition, the company offers insurance brokerage services, such as individual and business insurance policies to customers and general public; holds and markets real estate properties; mobile and internet banking services; debit and credit cards; and acts as trustee. It serves consumers, mid-sized and large businesses, and owners and developers of commercial real estate. As of September 30, 2020, the company had 234 branches located in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, and Texas. Washington Federal, Inc. was founded in 1917 and is headquartered in Seattle, Washington.
Earnings per Share
Washington Federal's trailing twelve-month EPS is $3.37.
PE Ratio
Washington Federal's trailing 12-month price-earnings ratio is 9.75. The purchaser of the shares is therefore investing $9.75 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 10.74%.Revenue Growth
Year-on-year quarterly revenue growth grew by 23.2%, now sitting on 657.96M for the twelve trailing months.
2. Saratoga Investment Corp New (SAR)
30.5% sales growth and 4.9% return on equity
Saratoga Investment Corp. is a business development company specializing in leveraged and management buyouts, acquisition financings, growth financings, recapitalization, debt refinancing, and transitional financing transactions at the lower end of middle market companies. It structures its investments as debt and equity by investing through first and second lien loans, mezzanine debt, co-investments, select high yield bonds, senior secured bonds, unsecured bonds, and preferred and common equity. It seeks to invest in the United States. The firm primarily invests $5 million to $20 million in companies having EBITDA of $2 million or greater and revenues of $8 million to $150 million. It invests through direct lending as well as participation in loan syndicates. The firm was formerly known as GSC Investment Corp. Saratoga Investment Corp. is based in New York, New York with an additional office in Florham Park, New Jersey.
Earnings per Share
Saratoga Investment Corp New's trailing 12 months EPS is $2.89.
PE Ratio
Saratoga Investment Corp New's trailing 12 months earnings to price ratio is 8.75. The purchaser of the shares is therefore investing $8.75 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 4.9%.Revenue Growth
Year-on-year quarterly revenue growth grew by 18.5%, now sitting on 76.01M for the twelve trailing months.
Volume
Today's last reported volume for Saratoga Investment Corp New is 18084 which is 48.43% below its average volume of 35072.
3. Zynex (ZYXI)
26.4% sales growth and 28.76% return on equity
Zynex, Inc., via its subsidiaries, develops, manufactures, markets and sells medical devices for chronic and acute pain. It also activates and exercises muscles with electric stimulation to rehabilitative and therapeutic purposes. The company offers NexWave a multi-channel, dual-channel, multimodality interferencential current and transcutaneous electrical nerve stimulation, (TENS) and neuromuscular electric stimulation device. It also sells NeuroMove and InWave which are electromyography-triggered stimulation devices. It also distributes electrodes to deliver electrical current to the body as well as batteries for electrotherapy products. Comfortrac is available for cervical traction and JetStream hot/cold therapy. LSO Back Braces are for lumbar support. It also offers a blood volume monitor which is a medical device that measures central blood volume. This can be used in recovery and operating rooms for internal bleeding detection and blood loss. It offers products to help with pain control, stroke rehabilitation and recovery from spinal cord injuries. Zynex, Inc. sells products primarily through its direct sales force in the United States. It was established in 1996. The headquarters are located in Englewood in Colorado.
Earnings Per Share
As for profitability, Zynex has a trailing twelve months EPS of $0.47.
PE Ratio
Zynex has a trailing twelve months price to earnings ratio of 34.68. Meaning, the purchaser of the share is investing $34.68 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.76%.Sales Growth
Zynex's sales growth is 23.1% for the current quarter and 26.4% for the next.
Yearly Top and Bottom Value
Zynex's stock is valued at $16.30 at 10:22 EST, below its 52-week high of $17.25 and way above its 52-week low of $4.97.
Volume
Today's last reported volume for Zynex is 310493 which is 43.61% above its average volume of 216201.
Growth Estimates Quarters
For the current quarter, the company expects a decline of 17.4% in growth and a rise of 66.7% the following.4. Avid Bioservices (CDMO)
24.3% sales growth and 101.81% return on equity
Avid Bioservices, Inc. is a contract-development and manufacturing company. It provides clinical and commercial manufacturing services, process development, and current good manufacturing practice (CGMP), for biopharmaceutical drugs substances derived from mammalian cells culture. The company produces monoclonal and recombinant antibodies. It also offers services such as CGMP commercial and clinical drug substance manufacturing, bulk packaging and release testing. It also offers process development services such as optimization and upstream development. The company serves pharmaceutical and biotechnology companies. Avid Bioservices, Inc. is a partner in the process development and manufacture of Oragenics, Inc.'s coronavirus vaccine. The former name of the company was Peregrine Pharmaceuticals, Inc., but it changed its name in January 2018 to Avid Bioservices, Inc. Avid Bioservices, Inc. is located in Tustin, California. It was established in 1981.
Earnings Per Share
As for profitability, Avid Bioservices has a trailing twelve months EPS of $1.65.
PE Ratio
Avid Bioservices has a trailing twelve months price to earnings ratio of 8.9. Meaning, the purchaser of the share is investing $8.9 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 101.81%.Yearly Top and Bottom Value
Avid Bioservices's stock is valued at $14.69 at 10:23 EST, way under its 52-week high of $23.57 and way higher than its 52-week low of $11.30.
Moving Average
Avid Bioservices is valued at above its $50-day moving mean of $14.56, and lower than its $200-day moving median of $16.31.Growth Estimates Quarters
For the current quarter, the company expects a decline of 175% to 200% in growth.Revenue growth
The year-over-year growth in quarterly revenue was 33.1%. We now have 134.18M to our credit for the 12 trailing months.
5. American Homes 4 Rent (AMH)
12.9% sales growth and 3.87% return on equity
American Homes 4 Rent (NYSE : AMH), a market leader in single-family rental, is rapidly becoming an internationally recognized brand. "American Homes 4 Rent", a national rental home company, is known for its high quality, great value, and tenants satisfaction. Our Maryland REIT is an internal managed real estate trust. It focuses on the acquisition, development, renovation, leasing and operation of attractive single-family rental homes. We owned 533,000 single-family homes in select submarkets of 22 states as of June 30, 2020.
Earnings Per Share
As for profitability, American Homes 4 Rent has a trailing twelve months EPS of $0.28.
PE Ratio
American Homes 4 Rent has a trailing twelve months price to earnings ratio of 117.26. Meaning, the purchaser of the share is investing $117.26 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.87%.Sales Growth
American Homes 4 Rent's sales growth for the next quarter is 12.9%.
6. Federal Realty Investment Trust (FRT)
6.9% sales growth and 13.32% return on equity
Federal Realty is an acknowledged leader in the management, ownership, and redevelopment high-quality, retail-based properties. These properties are primarily located in coastal cities from Washington, D.C., Boston, San Francisco, and Los Angeles. Federal Realty was founded in 1962. Its goal is to provide long-term sustainable growth by investing in densely populated and affluent areas where there is more retail demand than supply. Federal Realty's experience includes the creation of mixed-use urban neighborhoods such as Santana Row, San Jose, California; Pike & Rose, North Bethesda (Maryland); and Assembly Row, Somerville, Massachusetts. The unique, vibrant and lively environments, which combine dining, shopping, living, and work, provide an unforgettable experience for their communities. Federal Realty has 104 properties, with approximately 2900 tenants in 24,000,000 square feet and 2,800 housing units. Federal Realty's quarterly dividends have been increasing for 53 years consecutively, which is the longest streak in REITs. Federal Realty, a member of the S&P 500 index, is traded on the NYSE as the symbol FRT.
Earnings per Share
Federal Realty Investment Trust's trailing 12 months EPS is $4.76.
PE Ratio
Federal Realty Investment Trust's trailing 12-month price-to-earnings ratio is 21.5. The purchaser of the shares is therefore investing $21.5 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 13.32%.Annual Top and Bottom Value
Federal Realty Investment Trust stock was valued at $102.34 as of 10:23 EST. This is way below its 52 week high of $140.51 but way higher than its low 52-week of $86.43.
7. Range Resources Corporation (RRC)
5.7% sales growth and 75.37% return on equity
Range Resources Corporation operates as an independent natural gas, natural gas liquids (NGLs), and oil company in the United States. The company engages in the exploration, development, and acquisition of natural gas and oil properties. It holds interests in developed and undeveloped natural gas and oil leases in the Appalachian and North Louisiana regions of the United States. As of December 31, 2019, the company owned and operated 1,272 net producing wells and approximately 833,000 net acres under lease in the Appalachian region; and 409 net producing wells and approximately 105,000 net acres under lease in the North Louisiana region. It markets and sells natural gas, and NGLs to utilities, marketing and midstream companies, and industrial users; petrochemical end users, NGL distributors, and natural gas processors; and oil and condensate to crude oil processors, transporters, and refining and marketing companies. The company was formerly known as Lomak Petroleum, Inc. and changed its name to Range Resources Corporation in 1998. Range Resources Corporation was founded in 1976 and is headquartered in Fort Worth, Texas.
Earnings per Share
Range Resources Corporation's trailing 12 months EPS is $5.04.
PE Ratio
Range Resources Corporation's trailing 12-month price-earnings ratio is 4.89. The purchaser of the shares is therefore investing $4.89 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 75.37%.Sales Growth
Range Resources Corporation has a negative 11.1% quarter-over-quarter sales growth and 5.7% in the next.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Dec 13, 2022, the estimated forward annual dividend rate is 0.32 and the estimated forward annual dividend yield is 1.21%.